Xiaojing Shi

Affiliations: 
University of Southern California, Los Angeles, CA, United States 
Google:
"Xiaojing Shi"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cai M, Xu S, Jin Y, et al. (2023) hMOF induces cisplatin resistance of ovarian cancer by regulating the stability and expression of MDM2. Cell Death Discovery. 9: 179
Asmamaw MD, Shi XJ, Zhang LR, et al. (2022) A comprehensive review of SHP2 and its role in cancer. Cellular Oncology (Dordrecht). 45: 729-753
Cheng Q, Dai Z, Shi X, et al. (2021) Expanding the toolbox of exosome-based modulators of cell functions. Biomaterials. 277: 121129
Shi X, Zhang XN, Chen J, et al. (2020) A poly-ADP-ribose polymer-based antibody-drug conjugate. Chemical Science. 11: 9303-9308
Shi X, Zhang Y. (2020) A Humanized Antibody Inhibitor for Cathepsin L. Protein Science : a Publication of the Protein Society
Cheng Q, Shi X, Zhang Y. (2020) Reprogramming Exosomes for Immunotherapy. Methods in Molecular Biology (Clifton, N.J.). 2097: 197-209
Shi X, Cheng Q, Hou T, et al. (2019) Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy. Molecular Therapy : the Journal of the American Society of Gene Therapy
Shi X, Cheng Q, Zhang Y. (2019) Reprogramming Extracellular Vesicles with Engineered Proteins. Methods (San Diego, Calif.)
Cheng Q, Shi X, Han M, et al. (2018) Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity. Journal of the American Chemical Society
Lv Y, Song Y, Ni C, et al. (2018) Overexpression of Lymphocyte Antigen 6 Complex, Locus E in Gastric Cancer Promotes Cancer Cell Growth and Metastasis. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 45: 1219-1229
See more...